ABSTRACT NUMBER: ESOC2026A881 NEUROAID FUNCTIONAL AND MOTOR RECOVERY AFTER A MODERATELY SEVERE ISCHEMIC STROKE – META-ANALYSIS
Narayanaswamy Venketasubramanian, Christopher Chen · 2026
Read ABSTRACT NUMBER: ESOC2026A881 NEUROAID FUNCTIONAL AND MOTOR RECOVERY AFTER A MODERATELY SEVERE ISCHEMIC STROKE – META-ANALYSIS by Narayanaswamy Venketasubramanian, Christopher Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13145566.txt.
Description
Narayanaswamy Venketasubramanian and Christopher Chen present a 2026 conference review on a drug aimed at long-term recovery after mid-level stroke. Recovery after such strokes is often limited. The drug, sold as NeuroAiD, is meant to help the brain rebuild rather than just limit early harm.
The review pooled past studies that set the drug against a dummy pill in patients with mid-range stroke scores. Patients on the drug had higher odds of strong recovery, with clear gains at six and twelve months. In patients with marked arm and leg weakness at the start, gains showed by month three and held through month two years. No fading of the effect appeared over time.
Catalog record
| CREATOR | Narayanaswamy Venketasubramanian, Christopher Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |